Ronem 250 mg/vial (IV Injection or Infusion)
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Pneumonia and Nosocomial Pneumonia
- Urinary Tract Infections
- Intra-abdominal Infections
- Gynaecological Infections
- Skin and Skin Structure Infections
- Meningitis
- Septicaemia
- Pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
Exerts bactericidal action by interfering with bacterial cell wall synthesis. Potent bactericidal activity against a broad spectrum of Gram-positive and Gram-negative, aerobic and anaerobic bacteria.
Dosage
- Adults:
- Usual dose of 500 mg to 1 gm by intravenous administration every 8 hours
- Specific dosages for different infections: pneumonia, urinary tract infections, gynaecological infections, nosocomial pneumonias, peritonitis, intra-abdominal infections, cystic fibrosis, and meningitis
- Children:
- Dosage range of 10 to 40 mg/kg intravenously every 8 hours
- Specific dosages for different infections: intra-abdominal infections, cystic fibrosis, meningitis, and febrile neutropenia
- Instructions for children over 50 kg weight and lack of experience in children with hepatic or renal impairment
Administration
Administered by intravenous Infusion over approximately 15-30 minutes or as intravenous bolus (5 to 20 ml) over approximately 3-5 minutes
Interaction
Can be affected by Probenecid and can reduce serum valproic acid levels
Contraindications
Contraindicated in patients demonstrating hypersensitivity to the product
Side Effects
- Inflammation
- Thrombophlebitis
- Pain at the site of injection
- Skin reactions like rash, pruritus, urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy & Lactation
Pregnancy Category B. Should be used during pregnancy only if clearly needed. Caution should be exercised when administered to a nursing woman.
Precautions & Warnings
Discontinue if allergic reaction occurs. Use in patients with hepatic disease should be made with careful monitoring of transaminase and bilirubin levels.
Use in Special Populations
- Renal impairment: Dosage should be reduced in patients with creatinine clearance less than 51 ml/min.
- Hepatic impairment: No dosage adjustments are necessary.
- Elderly: No dosage adjustments are necessary unless creatinine clearance is less than 51 ml/min.
- Children: Efficacy and tolerability in infants under 3 months have not been established.
Overdose Effects
Accidental overdose could occur during therapy, particularly in patients with renal impairment. Treatment of overdose should be symptomatic.
Therapeutic Class
Other beta-lactam Antibiotics
Reconstitution
Instructions for preparation of solution for intravenous bolus and intravenous infusion administration. Compatibility with various infusion fluids.
Storage Conditions
Vial store in a cool, dry place (below 30°C), away from light & moisture. Keep out of the reach of children.
Related Brands
- Merostat 1 gm/vial (IV Injection or Infusion) - one-pharma-ltd
- Meropex 1 gm/vial (IV Injection or Infusion) - apex-pharmaceuticals-ltd
- Meroject 250 mg/vial (IV Injection or Infusion) - eskayef-pharmaceuticals-ltd
- G-Meropenem 500 mg/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd
- G-Meropenem 1 gm/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd